The EMBO Journal15d
Maintenance of p-eIF2α levels by the eIF2B complex is vital for colorectal cancer
Disrupting the eIF2Bα homodimer is detrimental for CRC cells. The ability to sense eIF2α phosphorylation is essential for CRC cell survival. Here we show that mutations essential for CRC development ...
Business Standard18d
Cash Flow
Amid increased scrutiny of price action in the SME segment by regulators and investors alike, a looks at their fundamentals in a three-part series. Part-1 examines sharp decline in operating cash flow ...
Pharmabiz18d
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
The combination of Illumina's Single Cell Prep, NovaSeq X Plus platform, 25B flow cell and DRAGEN analysis software creates a seamless end-to-end workflow enabling the high-throughput processing of ...
Investing21d
Illumina and Broad Clinical Labs enhance single-cell research
The integration of cutting-edge technologies is set to support the research community in undertaking billion-cell atlas studies, paving the way for new discoveries. Illumina's technology suite, ...
Finanznachrichten21d
Illumina, Inc.: Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
Longstanding partners bring together end-to-end workflows and leading CRISPR Perturb-seq technologies setting a standard for single-cell studies and enabling a 5 billion single-cell atlas ...
Nasdaq21d
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
The combination of Illumina's Single Cell Prep, NovaSeq™ X Plus platform, 25B flow cell and DRAGEN™ analysis software creates a seamless end-to-end workflow enabling the high-throughput ...